RAS p21 protein activator 1
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La RASA1 gene provides instructions for making a protein called p120-RasGAP. This protein helps regulate the RAS/MAPK signaling pathway, which transmits signals from outside the cell to the cell's nucleus. The RAS/MAPK signaling pathway helps direct several important cell functions, including the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), and cell movement. The p120-RasGAP protein is a negative regulator of the RAS/MAPK signaling pathway, which means it is involved in turning off these signals when they are not needed.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La RASA1 gene provides instructions for making a protein called p120-RasGAP. This protein helps regulate the RAS/MAPK signaling pathway, which transmits signals from outside the cell to the cell's nucleus. The RAS/MAPK signaling pathway helps direct several important cell functions, including the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), and cell movement. The p120-RasGAP protein is a negative regulator of the RAS/MAPK signaling pathway, which means it is involved in turning off these signals when they are not needed.
The exact role of p120-RasGAP is not fully understood. However, it appears to be essential for the normal development of the vascular system, which is the complex network of arteries, veins, and capillaries that carry blood to and from the heart.
Conditions referring to this gene or chromosome
Other names
DKFZp434N071
GAP
GTPase-activating protein
p120
p120GAP
p120RASGAP
ras GTPase-activating protein 1
RAS p21 protein activator (GTPase activating protein) 1
RASA
RASA1_HUMAN
RASGAP
triphosphatase-activating protein
Related patient information and medicines

Patient information leaflet
Polyarthrite rhumatoïde
The earlier treatment is started, the less joint damage is likely to occur. Surgery is needed in some cases if a joint becomes badly damaged. What is la polyarthrite rhumatoïde. Arthritis Arthritis means inflammation of joints. Polyarthrite rhumatoïde (PR) est a fairly common form of arthritis What's the difference between osteoarthritis and rheumatoid.

Patient information leaflet
Médicaments biologiques pour la polyarthrite rhumatoïde
Biological medicines are a newer type of medicine, used to ease le symptoms of rheumatoid arthritis and reduce the damaging effect of the disease on the joints.

Patient information leaflet
Médicaments antirhumatismaux modificateurs de la maladie
Médicaments antirhumatismaux modificateurs de la maladie (DMARDs) are medicines that are normally prescribed as soon as polyarthrite rhumatoïde (PR) is diagnosed, in order to reduce damage to the joints. Rarely, they can have serious side-effects affecting the blood, liver, or kidneys. Médicaments antirhumatismaux modificateurs de la maladie (DMARDs) are a group of les médicaments that are.

Patient information leaflet
dystrophie musculaire
Other people in the family can also be tested to see if they have a muscular dystrophy gene. Muscular dystrophy cannot be cured but there are various treatments which can help. What is muscular dystrophy. Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time)..

Patient information leaflet
Allaitement au biberon de votre bébé
What is cow's milk allergy. Allergie au lait de vache (ou cow's milk protein allergy, CMPA) is an allergy to one or more types of the main proteins in milk, casein and whey. It affects around 1 in 15 babies under a year old, although it is less common in exclusively breast-fed babies (only around 1 in 200), it is more common in babies who have, or whose.

Patient information leaflet
Maladie rénale diabétique
Maladie rénale diabétique is one of the causes of chronic kidney maladie Chronic kidney maladie , a long-term condition where the kidneys do not work as well as they should. In diabetic kidney disease, the filters of the kidneys, the glomeruli, become damaged. Because of this the kidneys 'leak' abnormal amounts of protein from the blood into the.
Lectures complémentaires et références
- RAS p21 protein activator 1; MedlinePlus, National Library of Medicine.
- Bayrak-Toydemir P, Stevenson DA. Capillary Malformation-Arteriovenous Malformation Syndrome. 2011 Feb 22 [updated 2019 Sep 12]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK52764/
- Boon LM, Mulliken JB, Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev. 2005 Jun;15(3):265-9. doi: 10.1016/j.gde.2005.03.004.
- Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, Vanwijck R, Vikkula M. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003 Dec;73(6):1240-9. doi: 10.1086/379793. Epub 2003 Nov 24.
- Friedman E, Gejman PV, Martin GA, McCormick F. Nonsense mutations in the C-terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours. Nat Genet. 1993 Nov;5(3):242-7. doi: 10.1038/ng1193-242.
- Kulkarni SV, Gish G, van der Geer P, Henkemeyer M, Pawson T. Role of p120 Ras-GAP in directed cell movement. J Cell Biol. 2000 Apr 17;149(2):457-70. doi: 10.1083/jcb.149.2.457.
- Revencu N, Boon LM, Mulliken JB, Enjolras O, Cordisco MR, Burrows PE, Clapuyt P, Hammer F, Dubois J, Baselga E, Brancati F, Carder R, Quintal JM, Dallapiccola B, Fischer G, Frieden IJ, Garzon M, Harper J, Johnson-Patel J, Labreze C, Martorell L, Paltiel HJ, Pohl A, Prendiville J, Quere I, Siegel DH, Valente EM, Van Hagen A, Van Hest L, Vaux KK, Vicente A, Weibel L, Chitayat D, Vikkula M. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008 Jul;29(7):959-65. doi: 10.1002/humu.20746.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

